Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Wullich

Showing results (141-150 of 251) with videos related to

Pageof 26
Sort By:
Translational Oncology|March 26, 2017
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder CancerDanijel Sikic, Johannes Breyer, Arndt Hartmann, et al.
International Journal of Cancer|July 30, 2010
Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cellsMarkus Greiner, Birgit Kreutzer, Volker Jung, et al.
BMC Cancer|March 19, 2024
NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimersJuan Guzman, Katrin Weigelt, Angela Neumann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 13, 2019
Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarraysMarkus Eckstein, Verena Sailer, Boye Schnack Nielsen, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma-No Evidence for a Role in CarcinogenesisAugust Fiegl, Olaf Wendler, Johannes Giedl, et al.
Cells|November 26, 2022
Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer PatientsVerena Lieb, Amer Abdulrahman, Katrin Weigelt, et al.
International Journal of Cancer|March 15, 2011
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screeningSven Wach, Elke Nolte, Jaroslaw Szczyrba, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
The Oncologist|July 12, 2019
Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)Ricarda Merten, Oliver Ott, Marlen Haderlein, et al.
Urologie (Heidelberg, Germany)|August 12, 2024
[Risk-adapted early detection program for prostate cancer 2.0-position paper of the German Society of Urology 2024]Maurice Stephan Michel, Jürgen E Gschwend, Bernd Wullich, et al.
Pageof 26

Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
Translational Oncology|March 26, 2017
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder CancerDanijel Sikic, Johannes Breyer, Arndt Hartmann, et al.
International Journal of Cancer|July 30, 2010
Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cellsMarkus Greiner, Birgit Kreutzer, Volker Jung, et al.
BMC Cancer|March 19, 2024
NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimersJuan Guzman, Katrin Weigelt, Angela Neumann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 13, 2019
Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarraysMarkus Eckstein, Verena Sailer, Boye Schnack Nielsen, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma-No Evidence for a Role in CarcinogenesisAugust Fiegl, Olaf Wendler, Johannes Giedl, et al.
Cells|November 26, 2022
Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer PatientsVerena Lieb, Amer Abdulrahman, Katrin Weigelt, et al.
International Journal of Cancer|March 15, 2011
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screeningSven Wach, Elke Nolte, Jaroslaw Szczyrba, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
The Oncologist|July 12, 2019
Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)Ricarda Merten, Oliver Ott, Marlen Haderlein, et al.
Urologie (Heidelberg, Germany)|August 12, 2024
[Risk-adapted early detection program for prostate cancer 2.0-position paper of the German Society of Urology 2024]Maurice Stephan Michel, Jürgen E Gschwend, Bernd Wullich, et al.
Pageof 26